Arlene Mou

Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ.

E. Kurniawan, A. Rose, Arlene Mou, 2010, Archives of surgery.

Outcomes of Screening-Detected Ductal Carcinoma In Situ Treated with Wide Excision Alone

E. Kurniawan, A. Rose, Arlene Mou, 2011, Annals of surgical oncology.

Predictors of Surgical Margin Status in Breast-Conserving Surgery Within a Breast Screening Program

Malcolm Buchanan, E. Kurniawan, A. Rose, 2008, Annals of surgical oncology.

Uptake of adjuvant breast cancer treatments recommended by multi‐disciplinary meetings

C. Nickson, A. Rose, Arlene Mou, 2018, ANZ journal of surgery.

Primary results of ANZ 1002: Post-operative radiotherapy omission in selected patients with early breast cancer trial (PROSPECT) following pre-operative breast MRI.

V. Gebski, A. Rose, Arlene Mou, 2022, Journal of Clinical Oncology.

Treatment Intensity Differences After Early-Stage Breast Cancer (ESBC) Diagnosis Depending on Participation in a Screening Program

C. Nickson, A. Rose, Arlene Mou, 2018, Annals of surgical oncology.

Contrast enhanced mammography in breast cancer surveillance

C. Nickson, A. Rose, Arlene Mou, 2022, Breast Cancer Research and Treatment.